Logo image of NMS

NUVEEN MN QLTY MUNI INC (NMS) Stock Overview

USA - NYSE:NMS - US6707341029

11.8 USD
-0.09 (-0.79%)
Last: 10/17/2025, 8:04:01 PM
Fundamental Rating

2

Overall NMS gets a fundamental rating of 2 out of 10. We evaluated NMS against 0 industry peers in the Unkown industry. Both the profitability and financial health of NMS have multiple concerns. NMS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year NMS was profitable.
In the past year NMS had a positive cash flow from operations.
In multiple years NMS reported negative net income over the last 5 years.
NMS had a positive operating cash flow in each of the past 5 years.
NMS Yearly Net Income VS EBIT VS OCF VS FCFNMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

1.2 Ratios

The last Return On Invested Capital (1.22%) for NMS is above the 3 year average (0.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.22%
ROE -0.37%
ROIC 1.22%
ROA(3y)-0.4%
ROA(5y)-0.24%
ROE(3y)-0.67%
ROE(5y)-0.54%
ROIC(3y)0.75%
ROIC(5y)1.17%
NMS Yearly ROA, ROE, ROICNMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5

1.3 Margins

NMS's Operating Margin has declined in the last couple of years.
NMS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 37.78%
PM (TTM) N/A
GM 39.63%
OM growth 3Y-15.03%
OM growth 5Y-8.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.36%
GM growth 5Y-7.87%
NMS Yearly Profit, Operating, Gross MarginsNMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100

2

2. Health

2.1 Basic Checks

The number of shares outstanding for NMS has been increased compared to 1 year ago.
Compared to 5 years ago, NMS has more shares outstanding
The debt/assets ratio for NMS is higher compared to a year ago.
NMS Yearly Shares OutstandingNMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
NMS Yearly Total Debt VS Total AssetsNMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

2.2 Solvency

Based on the Altman-Z score of 0.82, we must say that NMS is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of NMS is 27.47, which is on the high side as it means it would take NMS, 27.47 years of fcf income to pay off all of its debts.
NMS has a Debt/Equity ratio of 0.72. This is a neutral value indicating NMS is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 27.47
Altman-Z 0.82
ROIC/WACCN/A
WACCN/A
NMS Yearly LT Debt VS Equity VS FCFNMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

NMS has a Current Ratio of 3.05. This indicates that NMS is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 3.05 indicates that NMS has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.05
Quick Ratio 3.05
NMS Yearly Current Assets VS Current LiabilitesNMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M

1

3. Growth

3.1 Past

NMS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.75%.
NMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.98%.
The Revenue has been decreasing by -1.34% on average over the past years.
EPS 1Y (TTM)-93.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-416.67%
Revenue 1Y (TTM)22.98%
Revenue growth 3Y6.69%
Revenue growth 5Y-1.34%
Sales Q2Q%-17.84%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NMS Yearly Revenue VS EstimatesNMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

0

4. Valuation

4.1 Price/Earnings Ratio

NMS is valuated quite expensively with a Price/Earnings ratio of 590.00.
The average S&P500 Price/Earnings ratio is at 27.40. NMS is valued rather expensively when compared to this.
Industry RankSector Rank
PE 590
Fwd PE N/A
NMS Price Earnings VS Forward Price EarningsNMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 38.19
EV/EBITDA N/A
NMS Per share dataNMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.73%, NMS is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.38, NMS pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.73%

5.2 History

The dividend of NMS is nicely growing with an annual growth rate of 7.22%!
NMS has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of NMS decreased recently.
Dividend Growth(5Y)7.22%
Div Incr Years1
Div Non Decr Years1
NMS Yearly Dividends per shareNMS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of NMS are negative and hence is the payout ratio. NMS will probably not be able to sustain this dividend level.
DP-1865.38%
EPS Next 2YN/A
EPS Next 3YN/A
NMS Yearly Income VS Free CF VS DividendNMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

NUVEEN MN QLTY MUNI INC

NYSE:NMS (10/17/2025, 8:04:01 PM)

11.8

-0.09 (-0.79%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.44%
Inst Owner Change-2.89%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap69.50M
Analysts0
Price TargetN/A
Short Float %0.24%
Short Ratio0.96
Dividend
Industry RankSector Rank
Dividend Yield 6.73%
Yearly Dividend0.82
Dividend Growth(5Y)7.22%
DP-1865.38%
Div Incr Years1
Div Non Decr Years1
Ex-Date10-15 2025-10-15 (0.0665)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 590
Fwd PE N/A
P/S 14.27
P/FCF 38.19
P/OCF 38.19
P/B 0.99
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)0.02
EY0.17%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.31
FCFY2.62%
OCF(TTM)0.31
OCFY2.62%
SpS0.83
BVpS11.88
TBVpS11.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.22%
ROE -0.37%
ROCE 1.54%
ROIC 1.22%
ROICexc 1.22%
ROICexgc 1.22%
OM 37.78%
PM (TTM) N/A
GM 39.63%
FCFM 37.37%
ROA(3y)-0.4%
ROA(5y)-0.24%
ROE(3y)-0.67%
ROE(5y)-0.54%
ROIC(3y)0.75%
ROIC(5y)1.17%
ROICexc(3y)0.75%
ROICexc(5y)1.18%
ROICexgc(3y)0.75%
ROICexgc(5y)1.18%
ROCE(3y)0.96%
ROCE(5y)1.48%
ROICexcg growth 3Y-6.82%
ROICexcg growth 5Y-6.93%
ROICexc growth 3Y-6.82%
ROICexc growth 5Y-6.93%
OM growth 3Y-15.03%
OM growth 5Y-8.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.36%
GM growth 5Y-7.87%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 27.47
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.87
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.05
Quick Ratio 3.05
Altman-Z 0.82
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-416.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.98%
Revenue growth 3Y6.69%
Revenue growth 5Y-1.34%
Sales Q2Q%-17.84%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y116.47%
EBIT growth 3Y-9.35%
EBIT growth 5Y-9.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.53%
FCF growth 3Y-30.71%
FCF growth 5Y-13.65%
OCF growth 1Y-34.53%
OCF growth 3Y-30.71%
OCF growth 5Y-13.65%